Puma Biotechnology, Inc. (PBYI)
7.485
-0.02
(-0.33%)
USD |
NASDAQ |
May 01, 16:00
7.35
-0.14
(-1.80%)
After-Hours: 18:49
Puma Biotechnology Market Cap : 380.81M for May 1, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Rigel Pharmaceuticals, Inc. | 542.92M |
| Agios Pharmaceuticals, Inc. | 1.676B |
| Editas Medicine, Inc. | 282.85M |
| Trevi Therapeutics, Inc. | 1.780B |
| Phathom Pharmaceuticals, Inc. | 953.96M |
Market Cap Related Metrics
| PE Ratio | 12.25 |
| PS Ratio | 1.659 |
| PEG Ratio | 124.63 |
| Price to Book Value | 2.922 |
| Price to Free Cash Flow | 9.080 |
| Price | 7.485 |
| Earnings Yield | 8.16% |
| PEGY Ratio | 124.63 |
| Operating PE Ratio | 10.16 |
| Normalized PE Ratio | 12.25 |